Gregory Gorgas
Chief Executive Officer chez ARTELO BIOSCIENCES, INC.
Fortune : 30 260 $ au 31/03/2024
Profil
Gregory D.
Gorgas was the founder of Theragence, Inc. (founded in 2009) where he held the title of Managing Director from 2009 to 2011.
He is currently the President, CEO, CFO, Secretary & Treasurer at Artelo Biosciences, Inc. since 2017.
He is also a Director at Klotho Therapeutics, Inc. and Theragence, Inc. His former positions include Senior Director-Global & United States Marketing at Biogen, Inc. from 1997 to 2008, Senior Vice President-Commercial at Mast Therapeutics, Inc. from 2011 to 2017, and Senior Vice President-Commercial at Savara, Inc. He completed his undergraduate degree at The California State University and holds an MBA from the University of Phoenix.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARTELO BIOSCIENCES INC
0,63% | 22/03/2024 | 20 446 ( 0,63% ) | 30 260 $ | 31/03/2024 |
Postes actifs de Gregory Gorgas
| Sociétés | Poste | Début |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chief Executive Officer | 03/04/2017 |
Klotho Therapeutics, Inc.
 Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Klotho Therapeutics, Inc. operates as a biotechnology company. It develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease. The company was founded by James Plante in 2016 and is headquartered in San Diego, CA. | Director/Board Member | - |
Theragence, Inc.
 Theragence, Inc. Pharmaceuticals: MajorHealth Technology Theragence, Inc. provides pharmaceutical preparations. The private company is based in San Diego, CA. | Director/Board Member | - |
Anciens postes connus de Gregory Gorgas
| Sociétés | Poste | Fin |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2017 |
| SAVARA INC. | Corporate Officer/Principal | 28/12/2016 |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Theragence, Inc. provides pharmaceutical preparations. The private company is based in San Diego, CA. | Chief Executive Officer | 01/07/2011 |
| BIOGEN INC. | Sales & Marketing | 01/10/2008 |
Formation de Gregory Gorgas
| The California State University | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ARTELO BIOSCIENCES, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Theragence, Inc. provides pharmaceutical preparations. The private company is based in San Diego, CA. | Health Technology |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Klotho Therapeutics, Inc. operates as a biotechnology company. It develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease. The company was founded by James Plante in 2016 and is headquartered in San Diego, CA. | Commercial Services |
